Distal embolic protection during percutaneous intervention of aorto-coronary venous bypass grafts: The FIRST Trial

Clinical Research in Cardiology

Volumn 96, Issue 10, 2007, Pages 738-742

  Lins, Markus ^a   Heuer, Hubertus ^b   Haude, Michael ^c   Braun, Peter ^d   Stahl, Fabian ^e   Franz, Norbert ^f   Simon, Rüdiger ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ST JOHANNES HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d Herzzentrum Kaiser Wilhelm Krankenhaus   (Germany)

^e DEPARTMENT OF CARDIOLOGY   (Germany)

^f Schuchtermann Klinik   (Germany)

Author keywords

CABG; Embolization; MACE; PCI; Protection

Indexed keywords

AGED; ARTICLE; ASPIRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DEVICE; FEMALE; GERMANY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; VEIN GRAFT DISEASE;

AGED; AORTA; CORONARY ARTERY BYPASS; EMBOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 34848833511     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-007-0553-5     Document Type: Article

References (15)

1. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, Satler LF, Stone GW, Leon MB (1999) Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100:2400-2405
2. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS (1994) Incidence and treatment of "no-reflow" after percutaneous intervention. Circulation 89:2514-2518
3. Golino P, Piscione F, Benedict CR, Anderson HV, Capelli-Bigazzi M, Indolfi C, Condorelli M, Chiariello M, Willerson JT (1994) Local effect of serotonin released during coronary angioplasty. N Engl J Med 330:523-528
4. Webb JG, Carere RG, Virmani R, Baim D, Teirstein PS, Whitlow P, McQueen C, Kolodgie FD, Buller E, Mancini GB, Oesterle S (1999) Retrieval and analysis of particulate debris following saphenous vein graft intervention. J Am Coll Cardiol 34:468-475
5. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Baumann RP, Zuckermann BD, Chaitman BR, Bittl JA, Ohman EM (1998) Myonecrosis after revascularization procedures. J Am Coll Cardiol 31:241-251
6. Topol EJ, Yadav JS (2000) Recognition of the iomportance of embolization in atherosclerotic vascular disease. Circulation 101:570-580
7. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE (2002) Randomized trial of a distal embolic protection device during percutaneous intervention saphenous vein aorto-coronary bypass grafts. Circulation 105:1285-1290
8. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM, Brennan DM, Ellis SG, Topol EJ (2002) Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomizedclinical trials. Circulation 106:3063-3067
9. Carrozza JP Jr, Caussin C, Braden G, Braun P, Hansell F, Fatzinger R, Walters G, Kussmaul W, Breall J (2005) Embolic protection during saphenous vein graft intervention using a second- generation balloon protection device - results from the combined U.S. and European pilot study of the TriActiv Balloon Protected Flush Extraction System. Am Heart J 149:1136
10. Stankovic G, Colombo A, Presbitero P, van den Braden F, Inglese L, Cernigliaro C, Niccoli L, Bartorelli AL, Rubartelli P, Reifart N, Heyndrickx GR, Saunamaki K, Morice MC, Sgura FA, Di Mario C (2003) Randomized evaluation of polytetrafluoroethylenecovered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial. Circulation 108:37-42
11. Stone GW, Rogers C, Hermiller J, Feldmann R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA (2003) Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous aorto-coronary bypass grafts. Circulation 108:548-553
12. Gorog DA, Foale RA, Malik I (2005) Distal myocardial protection during percutaneous coronary intervention: when and where? J Am Coll Cardiol 46:1434-1445
13. BLAZE Clinical Registry Summary (FilterWire EZ System). http://www.bostonscientific.com
14. Carrozza JP Jr, Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C; PRIDE Study Investigators (2005) Randomized evaluation of the TriActiv Balloon Protection Flush Extraction System for the Treatment of Saphenous Vein Graft Disease. J Am Coll Cardiol 46:1677-1683
15. Reiber JHC (1991) An overview of coronary quantitation techniques as of 1989. In: Reiber JHC, Serruys PW (eds) Quantitative Coronary Arteriography. Kluwer Academic Publishers, Dordrecht/Boston/London, pp 55-132